Grant Program to Achieve HIV Epidemic Control in Subnational Units in Nigeria under PEPFAR

Deadline: 28-Feb-22

The Centers for Disease Control CGH has announced the applications for Delivering Comprehensive and Sustainable HIV/AIDS Clinical and Community Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President’s Emergency Plan for AIDS Relief (PEPFAR).

The overarching goal of this NOFO is to support the GON to rapidly achieve HIV epidemic control (a threshold where new HIV infections fall below AIDS-related deaths) in a subset of high-burden, high-prevalence SNUs in Nigeria. This NOFO also aims to ensure that PLHIV on life-saving ART continue to receive quality care and are virally suppressed, in accordance with UNAIDS 95-95-95 targets, which require having 95% of PLHIV tested and diagnosed, 95% of those diagnosed retained on ART, and 95% of those on ART virally suppressed.

The purpose of this NOFO is to accelerate targeted scale up of lifesaving ART across states in Nigeria with treatment coverage gaps within age and sex bands. In addition, this NOFO aims to strengthen HIV prevention programs including KP services and PMTCT at the community and facility levels. Overall, this NOFO seeks to sustain the gains of the ART scale up in the last 2 years by ensuring that clients are retained in care and virally suppressed while collaborating with GON and the CSOs to foster sustainability and program ownership.

Priorities

• Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence-based behavioral change and building programs to reduce mother-to-child transmission;
• Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs), and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
• Strengthening the capacity of countries to collect, use, and share surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring, and HIV screening for blood safety; and
• Developing, validating, and/or evaluating public health programs to inform, improve, and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB, and opportunistic infections.

Funding Information

• Approximate Total Fiscal Year Funding: $160,000,000
• Total Period of Performance Length: 5
• The expected number of awards is 2-4.
• Approximate Average Award: $40,000,000 Per Budget Period
• Budget Period Length: 12 month(s)

Outcomes

• Short-Term Outcomes:
  • Improved effective linkage and enrollment in care of high-risk, underserved newly diagnosed and returned PLHIV across all ages, sexes, and geographic locations
  • Optimized treatment continuity and durable viral suppression among adult and pediatric clients
  • Increased access to effective HIV prevention services for at-risk populations
    • Prevention services include interventions such as pre-exposure prophylaxis, postexposure prophylaxis and combination prevention approaches tailored to individual client needs
  • Increased skilled workforce conducting timely and quality diagnostic services for clinical care at health facility and community levels
  • Improved availability and reliability of patient data for monitoring, planning, and implementation
• Intermediate Outcomes:
  • Increased coverage of ART among PLHIV
    • Coverage refers to the proportion of PLHIV enrolled and maintained on treatment within a given period. Increased coverage means closing the population-level HIV/AIDS treatment gap
  • Increased uptake of HIV testing, diagnosis and linkage for high-risk persons and underserved populations across all ages, sexes, and geographic locations
  • Increased uptake of evidence-based HIV prevention services for at-risk populations
    • Evidence-based refers to prevention approaches that have been implemented in research or public health settings and are found to be effective and scalable
  • Improved clinical management of HIV through utilization of diagnostic services to optimize patient care
    • Utilization of diagnostic services refers to ensuring appropriate requisition of laboratory tests, timely return of results, and access to patient-level test results for clinical decision making
  • Improved utilization of patient-level HIV service delivery data for CQI
• Long-Term Outcomes:
  • Achieved sustainable epidemic control for HIV across sub-populations and sub-national geographies including eMTCT
    • Sustainable epidemic control refers to maintaining the rate of new HIV infections below the rate of AIDS-related deaths
  • Sustained ability of state governments and CSOs to lead and manage comprehensive HIV programs

Target Populations

The target populations for this NOFO include persons infected with HIV and those at risk of HIV infection which includes KPs e.g., people who inject drugs, men who have sex with men, female sex workers, and other high-risk groups as determined by the most recent contextual evidence. The Nigeria program seeks to focus its HIV program scale-up efforts across all at-risk populations as well as age and sex bands in high-burden geographic areas to achieve HIV epidemic control.

Eligibility Criteria

• Government Organizations:
• State governments or their bona fide agents (includes the District of Columbia)
• Local governments or their bona fide agents
• Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau
• American Indian or Alaska Native tribal governments (federally recognized or state-recognized)
• State controlled institutions of higher education
• Non-government Organizations
• American Indian or Alaska native tribally designated organizations
• Other
• Ministries of Health

For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=335098

NEXT>>
<<PREVIOUS